|
Return to Press Releases
View Archived
For immediate release
NUCRYST Pharmaceuticals to Release First Quarter 2008 Financial Results on May 6, 2008
WAKEFIELD, MA, April 29, 2008 -- NUCRYST Pharmaceuticals Corp (NASDAQ: NCST; TSX: NCS), a developer and manufacturer of medical products that fight infection and inflammation, will release first quarter 2008 financial results on Tuesday, May 6, 2008. The company will host a conference call that day at 4:30 PM ET to discuss the financial results for the quarter.
Conference call details:
Date: Tuesday, May 6, 2008
Time: 4:30 PM ET
Dial-in: 866-202-4367 (U.S.)
617-213-8845 (International)
Passcode: 98073917
Web cast: http://www.nucryst.com (Investor Relations section)
An audio replay of the call will be available for seven days:
Access: 888-286-8010 (U.S.)
617-801-6888 (International)
Replay Passcode: 16575319
In addition to the standard disclosure over wire services, a news release and financial statements will be posted on the NUCRYST website.
About NUCRYST Pharmaceuticals
NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology. Smith & Nephew plc sell a range of advanced wound care products under their Acticoat™ trade mark. Acticoat™ products incorporate NUCRYST’s SILCRYST™ coatings and are sold in over 30 countries. NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by both infection and inflammation. The Company has developed its proprietary nanocrystalline silver in a powder form, referred to as NPI 32101 for use in medical devices and as an active pharmaceutical ingredient.
For more information, contact:
Gregory W. Gin
Lazar Partners
212.867.1762
info@nucryst.com
Acticoat™ is a trademark of Smith & Nephew plc
SILCRYST™ is a trademark of NUCRYST Pharmaceuticals Corp.
Return to Press Releases
View Archived
|
